- 2015
- What's on? - 09.03.2015
Thursday 12 March: French National Ear Care Day
According to the World Health Organization (WHO), more than 5% of the world population, i.e. 360 million people, suffers from disabling hearing loss (hearing loss greater than 40 decibels (dB) in the better hearing ear in adults, and 30 dB in the better hearing ear in children), or 328 million adults and 32 million children. […]
- News in brief - 09.03.2015
Lack of consensus on obstetric practices between countries of the European Union
The rate of caesarean deliveries varies considerably throughout Europe, according to a new study from the EURO-PERISTAT project, published in BJOG: An International Journal of Obstetrics and Gynaecology. We know that the likelihood of a caesarean delivery is greater for women in their first pregnancy, for women who have already had a caesarean section, and […]
- Press releases - 03.03.2015
Sleep reduces the brain’s predictive ability
A study carried out at NeuroSpin (French Atomic Energy Commission [CEA]/Inserm) has shown that even though sounds continue to penetrate the auditory cortex, sleep disrupts the brain’s ability to anticipate them
- Press releases - 02.03.2015
Médecine/sciences (m/s) journal is 30 years old
To celebrate the 30 years of the Médecine/sciences journal, a colloquium is organised the thursday 12th March by Inserm at the Pasteur Institute
- Press releases - 27.02.2015
VEGF-C, an indispensable growth factor for producing new neurons
Research studies bringing together Inserm, CNRS and Université de Pierre et Marie Curie researchers from the Brain and Spinal Cord Institute in collaboration with a team from the Yale Cardiovascular Research Center, have demonstrated the importance of factor VEGF-C in the activation of neural stem cells, and hence in the production of new neurons.
- Press releases - 26.02.2015
European Patent Office rankings for 2014: Inserm 6th in France for patent applications, 1st in Europe for patent applications in biomedical research
Inserm, with the help of its subsidiary Inserm Transfert, continues to rise in the 2014 rankings of French patent applicants issued by the European Patent Office (EPO)
- Press releases - 26.02.2015
Saturday 28 February: World rare disease day
A disease is said to be rare if it affects fewer than 1 in 2,000 people, or, for France, fewer than 30,000 people for a given disease.
- What's on? - 26.02.2015
Saturday 28 February: World rare disease day
A disease is said to be rare if it affects fewer than 1 in 2,000 people, or, for France, fewer than 30,000 people for a given disease. Rare diseases are highly diverse, are found in all areas of medicine, and are often serious, chronic, and progressive. The theme chosen for this 8th World Rare Disease Day, “Living […]
- Press releases - 24.02.2015
Preliminary results of the JIKI clinical trial to test the efficacy of favipiravir in reducing mortality in individuals infected by Ebola virus in Guinea.
Preliminary data from the JIKI clinical trial, which is testing the efficacy of favipiravir in reducing mortality associated with Ebola, provide two important pieces of information:
• absence of efficacy in individuals who arrive at treatment centres with a very high level of viral replication and who already have serious visceral involvement,
• and encouraging signs of efficacy in individuals arriving at treatment centres with a high or moderate level of viral replication, who have not yet developed overly severe visceral lesions.
With this classification into two groups, we have a much better understanding of Ebola virus disease, and can redefine the role of antiviral monotherapies in the therapeutic arsenal used against the disease.
The trial, sponsored by Inserm and funded by the European Commission from the Horizon 2020 Initiative under the project title REACTION, is supported by two NGOs, Médecins Sans Frontières/Doctors Without Borders (MSF) and Alliance for International Medical Action (ALIMA); two laboratory networks, Belgian First Aid and Support Team (B-FAST) and European Mobile Laboratory (EMLab); the French Red Cross, and the French Military Health Service.
These preliminary data are being presented on Wednesday 25 February as a late-breaking abstract at the CROI international conference (Conference on Retroviruses and Opportunistic Infections) in Seattle. - News in brief - 23.02.2015
Long-term consequences of stress experienced in childhood
Exposure to stress during sensitive periods of development in childhood could alter the functioning of the various physiological systems and affect health in the long term. This has been revealed by a study conducted by the Inserm team led by Cyrille Delpierre, Inserm Research Fellow, and published in PNAS. Adverse experiences in childhood may take […]